The government recruits a scientist to go undercover as a spy to gather information about a serum to cure the rampant disease.
The largest pharma-tech company weighs the advantages of a consortium to battle a global health crisis.
A major entity within the pharmaceutical consortium discusses the ramifications of the President’s international speech.
Premiere: As the year 2100 approaches, this world teeters on the edge of a new era—or human extinction in this novella miniseries.
All alone, with limited resources, and fearful that others are tracking him, Dennis tries his best to maintain his sanity without advanced technology.
Dennis makes a risky move for assistance while trying to evade authorities. Meanwhile, Abigail has a moment of clarity regarding their plight.
Before cutting loose from society entirely, Dennis and Abigail explore ways to stay off the grid. Do they blend in with crowds or remain on backstreets?
With Dennis and Abigail in the wind, their boss tries to piece together omissions in their data and track them down.
Without great options after returning home early from a doctor’s visit, Dennis contemplates life on the run while access to technology remains.
Dennis has the task of confirming Abigail’s suspicions. To gather more information, he needs to get from beneath his boss’s oversight.
Dennis leaves for some weekend recreation with a workmate, but his problems appear to multiply.
Premiere: During the year 2067, smart homes, autonomous vehicles, and other technologies overtake essential services to bend reality in this sci-fi novella miniseries.
Featured authors and reviewers
This information does not constitute professional medical care or legal advice. Discuss personal concerns with your doctor or legal advisor.